Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

NAD+-dependent 15-hydroxyprostaglandin dehydrogenase regulates levels of bioactive lipids in non-small cell lung cancer.

Hughes D, Otani T, Yang P, Newman RA, Yantiss RK, Altorki NK, Port JL, Yan M, Markowitz SD, Mazumdar M, Tai HH, Subbaramaiah K, Dannenberg AJ.

Cancer Prev Res (Phila). 2008 Sep;1(4):241-9. doi: 10.1158/1940-6207.CAPR-08-0055.

2.

Ciglitazone mediates COX-2 dependent suppression of PGE2 in human non-small cell lung cancer cells.

Hazra S, Dubinett SM.

Prostaglandins Leukot Essent Fatty Acids. 2007 Jul;77(1):51-8. Epub 2007 Aug 13.

3.

NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer.

Ding Y, Tong M, Liu S, Moscow JA, Tai HH.

Carcinogenesis. 2005 Jan;26(1):65-72. Epub 2004 Sep 9.

PMID:
15358636
4.

Regulation of 15-hydroxyprostaglandin dehydrogenase expression in hepatocellular carcinoma.

Castro-Sánchez L, Agra N, Llorente Izquierdo C, Motiño O, Casado M, Boscá L, Martín-Sanz P.

Int J Biochem Cell Biol. 2013 Nov;45(11):2501-11. doi: 10.1016/j.biocel.2013.08.005. Epub 2013 Aug 15.

PMID:
23954207
5.

15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer.

Backlund MG, Mann JR, Holla VR, Buchanan FG, Tai HH, Musiek ES, Milne GL, Katkuri S, DuBois RN.

J Biol Chem. 2005 Feb 4;280(5):3217-23. Epub 2004 Nov 12.

6.

Inhibition of epidermal growth factor receptor signaling elevates 15-hydroxyprostaglandin dehydrogenase in non-small-cell lung cancer.

Yang L, Amann JM, Kikuchi T, Porta R, Guix M, Gonzalez A, Park KH, Billheimer D, Arteaga CL, Tai HH, DuBois R, Carbone DP, Johnson DH.

Cancer Res. 2007 Jun 15;67(12):5587-93.

7.

Inducible prostaglandin E synthase is overexpressed in non-small cell lung cancer.

Yoshimatsu K, Altorki NK, Golijanin D, Zhang F, Jakobsson PJ, Dannenberg AJ, Subbaramaiah K.

Clin Cancer Res. 2001 Sep;7(9):2669-74.

8.

UV radiation inhibits 15-hydroxyprostaglandin dehydrogenase levels in human skin: evidence of transcriptional suppression.

Judson BL, Miyaki A, Kekatpure VD, Du B, Gilleaudeau P, Sullivan-Whalen M, Mohebati A, Nair S, Boyle JO, Granstein RD, Subbaramaiah K, Krueger JG, Dannenberg AJ.

Cancer Prev Res (Phila). 2010 Sep;3(9):1104-11. doi: 10.1158/1940-6207.CAPR-10-0089. Epub 2010 Jul 19.

9.

Prostaglandin catabolic enzymes as tumor suppressors.

Tai HH.

Cancer Metastasis Rev. 2011 Dec;30(3-4):409-17. doi: 10.1007/s10555-011-9314-z. Review.

PMID:
22020925
10.

Mechanical stress and prostaglandin E2 synthesis in cartilage.

Gosset M, Berenbaum F, Levy A, Pigenet A, Thirion S, Cavadias S, Jacques C.

Biorheology. 2008;45(3-4):301-20. Erratum in: Biorheology. 2012;49(4):299.

PMID:
18836232
11.

Prostaglandin E2 regulates its own inactivating enzyme, 15-PGDH, by EP2 receptor-mediated cervical cell-specific mechanisms.

Kishore AH, Owens D, Word RA.

J Clin Endocrinol Metab. 2014 Mar;99(3):1006-18. doi: 10.1210/jc.2013-3392. Epub 2014 Jan 28.

12.

IL-4 regulates COX-2 and PGE2 production in human non-small cell lung cancer.

Cui X, Yang SC, Sharma S, Heuze-Vourc'h N, Dubinett SM.

Biochem Biophys Res Commun. 2006 May 19;343(4):995-1001. Epub 2006 Mar 23.

PMID:
16574063
14.

Regulation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by non-steroidal anti-inflammatory drugs (NSAIDs).

Tai HH, Chi X, Tong M.

Prostaglandins Other Lipid Mediat. 2011 Nov;96(1-4):37-40. doi: 10.1016/j.prostaglandins.2011.06.005. Epub 2011 Jul 6. Review.

PMID:
21763448
15.

NAD+-linked 15-hydroxyprostaglandin dehydrogenase: structure and biological functions.

Tai HH, Cho H, Tong M, Ding Y.

Curr Pharm Des. 2006;12(8):955-62. Review.

PMID:
16533162
16.

15-Hydroxyprostaglandin dehydrogenase is a target of hepatocyte nuclear factor 3beta and a tumor suppressor in lung cancer.

Huang G, Eisenberg R, Yan M, Monti S, Lawrence E, Fu P, Walbroehl J, Löwenberg E, Golub T, Merchan J, Tenen DG, Markowitz SD, Halmos B.

Cancer Res. 2008 Jul 1;68(13):5040-8. doi: 10.1158/0008-5472.CAN-07-6575.

17.

Prostaglandin E2 synthesis in cartilage explants under compression: mPGES-1 is a mechanosensitive gene.

Gosset M, Berenbaum F, Levy A, Pigenet A, Thirion S, Saffar JL, Jacques C.

Arthritis Res Ther. 2006;8(4):R135.

18.

15-hydroxyprostaglandin dehydrogenase (15-PGDH) prevents lipopolysaccharide (LPS)-induced acute liver injury.

Yao L, Chen W, Song K, Han C, Gandhi CR, Lim K, Wu T.

PLoS One. 2017 Apr 19;12(4):e0176106. doi: 10.1371/journal.pone.0176106. eCollection 2017.

19.

Experimental cancer therapy using restoration of NAD+ -linked 15-hydroxyprostaglandin dehydrogenase expression.

Kaliberova LN, Kusmartsev SA, Krendelchtchikova V, Stockard CR, Grizzle WE, Buchsbaum DJ, Kaliberov SA.

Mol Cancer Ther. 2009 Nov;8(11):3130-9. doi: 10.1158/1535-7163.MCT-09-0270. Epub 2009 Nov 3.

Supplemental Content

Support Center